|
1
|
Schreckenbach T, Zeller MV, El Youzouri H,
Bechstein WO and Woeste G: Identification of factors predictive of
postoperative morbidity and short-term mortality in older patients
after colorectal carcinoma resection: A single-center retrospective
study. J Geriatr Oncol. 9:649–658. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Issa AM, Hutchinson JF, Tufail W, Fletcher
E, Ajike R and Tenorio J: Provision of personalized genomic
diagnostic technologies for breast and colorectal cancer: An
analysis of patient needs, expectations and priorities. Per Med.
8:401–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhen Y, Luo C and Zhang H: Early detection
of ulcerative colitis-associated colorectal cancer. Gastroenterol
Rep (Oxf). 6:83–92. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mansfield C, Ekwueme DU, Tangka FKL, Brown
DS, Smith JL, Guy GP Jr, Li C and Hauber B: Colorectal cancer
screening: Preferences, past behavior, and future intentions.
Patient. 11:599–611. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Satake H, Sunakawa Y, Miyamoto Y, Nakamura
M, Nakayama H, Shiozawa M, Makiyama A, Kobayashi K, Kubota Y, Mori
M, et al: A phase II trial of 1st-line modified-FOLFOXIRI plus
bevacizumab treatment for metastatic colorectal cancer harboring
RAS mutation: JACCRO CC-11. Oncotarget. 9:18811–18820. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ihnát P, Vávra P, Slívová I, Tulinský L
and Penka I: Radiotherapy in the treatment of rectal cancer is it
time to move on? Rozhl Chir. 97:156–160. 2018.(In Czech).
PubMed/NCBI
|
|
7
|
Hathout L, Maloney-Patel N, Malhotra U,
Wang SJ, Chokhavatia S, Dalal I, Poplin E and Jabbour SK:
Management of locally advanced rectal cancer in the elderly: A
critical review and algorithm. J Gastrointest Oncol. 9:363–376.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olkkonen VM, Peterson JR, Dupree P, Lütcke
A, Zerial M and Simons K: Isolation of a mouse cDNA encoding Rab23,
a small novel GTPase expressed predominantly in the brain. Gene.
138:207–211. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Evans TM, Ferguson C, Wainwright BJ,
Parton RG and Wicking C: Rab23, a negative regulator of hedgehog
signaling, localizes to the plasma membrane and the endocytic
pathway. Traffic. 4:869–884. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo A, Wang T, Ng EL, Aulia S, Chong KH,
Teng FY, Wang Y and Tang BL: Open brain gene product Rab23:
Expression pattern in the adult mouse brain and functional
characterization. J Neurosci Res. 83:1118–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eggenschwiler JT, Espinoza E and Anderson
KV: Rab23 is an essential negative regulator of the mouse Sonic
hedgehog signalling pathway. Nature. 412:194–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jian Q, Miao Y, Tang L, Huang M, Yang Y,
Ba W, Liu Y, Chi S and Li C: Rab23 promotes squamous cell carcinoma
cell migration and invasion via integrin β1/Rac1 pathway.
Oncotarget. 7:5342–5352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Yu F, Wang Y, Zhang Y, Meng L and
Chi Y: Rab23 promotes the cisplatin resistance of ovarian cancer
via the Shh-Gli-ABCG2 signaling pathway. Oncol Lett. 15:5155–5160.
2018.PubMed/NCBI
|
|
14
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC cancer staging manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng C, Wen M and Liu X: Fibroblast
activation protein in osteosarcoma cells promotes angiogenesis via
AKT and ERK signaling pathways. Oncol Lett. 15:6029–6035.
2018.PubMed/NCBI
|
|
16
|
Wang M, Dong Q and Wang Y: Rab23 is
overexpressed in human astrocytoma and promotes cell migration and
invasion through regulation of Rac1. Tumour Biol. 37:11049–11055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu YJ, Wang Q, Li W, Huang XH, Zhen MC,
Huang SH, Chen LZ, Xue L and Zhang HW: Rab23 is a potential
biological target for treating hepatocellular carcinoma. World J
Gastroenterol. 13:1010–1017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Y, Han Y, Sun C, Han C, Han N, Zhi W
and Qiao Q: Rab23 is overexpressed in human bladder cancer and
promotes cancer cell proliferation and invasion. Tumour Biol.
37:8131–8138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang J, Xu W, Liu G, Du X and Li X:
Downregulation of Rab23 in prostate cancer inhibits tumor growth in
vitro and in vivo. Oncol Res. 25:241–248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Zeng C, Bao N, Zhao J, Hu Y, Li C
and Chi S: Effect of Rab23 on the proliferation and apoptosis in
breast cancer. Oncol Rep. 34:1835–1844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu J, Pan X and Hu Z: MiR-502 mediates
esophageal cancer cell TE1 proliferation by promoting AKT
phosphorylation. Biochem Biophys Res Commun. 501:119–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zohrap N, Saatci Ö, Ozes B, Coban I, Atay
HM, Battaloglu E, Şahin Ö and Bugra K: SIK2 attenuates
proliferation and survival of breast cancer cells with simultaneous
perturbation of MAPK and PI3K/Akt pathways. Oncotarget.
9:21876–21892. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao WF, Liu JW and Huang DS: MiR-200a
inhibits cell proliferation and EMT by down-regulating the ASPH
expression levels and affecting ERK and PI3K/Akt pathways in human
hepatoma cells. Am J Transl Res. 10:1117–1130. 2018.PubMed/NCBI
|
|
24
|
Qi Z, Yin L, Xu Y and Wang F: Pegylated
liposomal-paclitaxel induces ovarian cancer cell apoptosis via
TNF-induced ERK/AKT signaling pathway. Mol Med Rep. 17:7497–504.
2018.PubMed/NCBI
|
|
25
|
Park CH, Han SE, Nam-Goong IS, Kim YI and
Kim ES: Combined effects of baicalein and docetaxel on apoptosis in
8505c anaplastic thyroid cancer cells via downregulation of the ERK
and Akt/mTOR pathways. Endocrinol Metab (Seoul). 33:121–132. 2018.
View Article : Google Scholar : PubMed/NCBI
|
